Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Harnessing Mobile Devices for Nervous System Disorders ...
Released: November 19, 2018
To explore current developments and opportunities for using mobile technology to advance research and treatment of central nervous system (CNS) disorders, the National Academies’ Forum on Neuroscience and Nervous System Disorders hosted a workshop on June 5–6, 2018.
Understanding the Economics of Microbial Threats ...
Released: October 15, 2018
On June 11-12, 2018, the Forum on Microbial Threats at the National Academies of Sciences, Engineering, and Medicine organized a 1.5-day public workshop to assess the current understanding of the interaction of infectious disease threats with economic activity and suggest new areas of research. This workshop built on prior work of the Forum and aimed to build more mutual understanding between those in the economic world and those with public health and clinical experience. Through multisectoral participation, topics in the workshop identified potential knowledge gaps, research priorities for further exploration, and strategies to advance the field in understanding the economics of microbial threats.
Implementing Quality Measures for Accountability in ...
Released: October 01, 2018
The Roundtable on Quality Care for People with Serious Illness of the National Academies of Sciences, Engineering and Medicine held a public workshop on April 17, 2018 in Washington, D.C., to explore the challenges and opportunities related to implementing quality measures for accountability purposes in community-based care for people with serious illness.
Medical Product Shortages During Disasters: Opportunities to ...
Released: September 28, 2018
The National Academies of Sciences, Engineering, and Medicine convened a workshop to better understand the gaps that led to cascading effects in patient care throughout the U.S. health care system. On September 5–6, 2018, in Washington, DC, the Health and Medicine Division of the National Academies convened the workshop Medical Product Shortages During Disasters: Opportunities to Predict, Prevent, and Respond.
Neuroforensics: Exploring the Legal Implications of Emerging ...
Released: July 06, 2018
On March 6, 2018, the Forum on Neuroscience and Nervous System Disorders, in collaboration with the Committee on Science, Technology, and Law (CSTL), held a public workshop to explore and advance efforts to identify and evaluate the potential effects of emerging neurotechnologies on the legal system.
Urbanization and Slums: Infectious Diseases in the Built ...
Released: June 08, 2018
On December 12-13, the Forum on Microbial Threats, in collaboration with the Board on Life Sciences hosted a workshop examining "Urbanization and Slums: New Transmission Pathways of Infectious Diseases in the Built Environment."
Financing and Payment Strategies to Support High-Quality ...
Released: May 16, 2018
Those facing serious illness have a range of interconnected medical and non-medical needs, and the way their care is financed has a large impact on the care they receive. Medicare is the predominant payer, but both Medicaid and private payers also play significant roles in financing care for serious illness. In an effort to address the complex needs of people with serious illness, public and private health care payers are testing innovative financing strategies and alternative payment models.
Advancing Therapeutic Development for Pain and Opioid Use ...
Released: March 23, 2018
Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. In parallel with increasing recognition of the need to treat chronic pain, the opioid epidemic has emerged as a growing public health emergency. In 2017, the National Institutes of Health began exploring public-private partnerships to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To help inform this effort, the National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together experts and stakeholders from academia, federal agencies, advocacy organizations, and companies developing therapeutics for pain and opioid use disorders.
Enabling Novel Treatments for Nervous System Disorders by ...
Released: March 08, 2018
The blood-brain barrier (BBB) presents a special challenge to the development of therapeutics for many central nervous system (CNS) disorders. Far from acting simply as a physical barrier, the BBB is a complex dynamic system involving several cell types, passive and active transport mechanisms, and adaptive function to control the exchange of substances between the blood and the CNS. Few therapeutic agents readily traverse the BBB to reach the brain or spinal cord, including most small molecule drugs and the vast majority of large molecules such as proteins.
Combating Antimicrobial Resistance: A One Health Approach ...
Released: December 08, 2017
To build on previous work, to explore developments since the last workshop was convened, and to help parlay knowledge into immediate action, an ad hoc planning committee, under the auspices of the Forum of Microbial Threats at the National Academies, planned a 2-day public workshop Combating Antimicrobial Resistance: A One Health Approach to a Global Threat. The workshop explored issues of antimicrobial resistance through the lens of One Health, which is a collaborative approach of multiple disciplines—working locally, nationally, and globally—for strengthening systems to counter infectious diseases and related issues that threaten human, animal, and environmental health, with an end point of improving global health and achieving gains in development.